Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CZO | TSXV | CAD | Delayed | |
CZO | CBOE Canada | CAD | Real-time |
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.
Name | Age | Since | Title |
---|---|---|---|
Gilles R. Gagnon | 69 | 2007 | CEO, President & Director |
Ronald W. Miller | - | 2022 | Independent Chairman |
William W. Li | 60 | 2014 | Independent Director |
Genevieve Foster | - | 2022 | Independent Director |
Ulrich Kosciessa | - | 2015 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review